NEW YORK, April 1 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb today announced the results of its cash tender offer to purchase any and all of its outstanding $2.5 billion aggregate principal amount 4.75% Notes due 2006, CUSIP No. 110122 AF 5 (the "Notes"). The offer commenced on Wednesday, March 23, 2005, and expired at 5 p.m., ET, Thursday, March 31, 2005.
The depositary agent, Global Bondholder Services Corporation, has informed the Company that an aggregate principal amount of $1,381,046,000 of the Notes was tendered in the offer.
Bristol-Myers Squibb today also issued a notice of mandatory redemption with respect to all Notes that remain outstanding following consummation of the tender offer. All Notes that remain outstanding following the consummation of the tender offer will be redeemed on Monday, May 2, 2005, at the previously disclosed redemption price of $1,014.06 per $1,000 principal amount.
Bristol-Myers Squibb Company is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.
CONTACT: Media: Brian Henry, Communications, +1-609-252-3337, email@example.com, or Investors: John Elicker, Investor Relations,+1-212-546-3775, or firstname.lastname@example.org, both of Bristol-Myers Squibb